1. Home
  2. ADAG vs FXNC Comparison

ADAG vs FXNC Comparison

Compare ADAG & FXNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adagene Inc.

ADAG

Adagene Inc.

N/A

Current Price

$3.88

Market Cap

254.4M

Sector

Health Care

ML Signal

N/A

Logo First National Corporation

FXNC

First National Corporation

HOLD

Current Price

$27.87

Market Cap

265.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAG
FXNC
Founded
2011
1907
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
254.4M
265.0M
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
ADAG
FXNC
Price
$3.88
$27.87
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$8.25
N/A
AVG Volume (30 Days)
95.1K
65.7K
Earning Date
04-01-2026
05-12-2026
Dividend Yield
N/A
2.43%
EPS Growth
N/A
96.00
EPS
N/A
0.54
Revenue
N/A
$7,717,000.00
Revenue This Year
N/A
$12.21
Revenue Next Year
N/A
$2.93
P/E Ratio
N/A
$51.59
Revenue Growth
N/A
7.40
52 Week Low
$1.44
$18.35
52 Week High
$4.75
$29.85

Technical Indicators

Market Signals
Indicator
ADAG
FXNC
Relative Strength Index (RSI) 50.91 54.24
Support Level $3.35 $26.39
Resistance Level $3.99 $28.66
Average True Range (ATR) 0.32 0.77
MACD 0.01 0.05
Stochastic Oscillator 66.46 71.28

Price Performance

Historical Comparison
ADAG
FXNC

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.

Share on Social Networks: